Evolution of insulin at the edge of foldability and its medical implications
Proteins have evolved to be foldable, and yet determinants of foldability may be inapparent once the native state is reached. Insight has emerged from studies of diseases of protein misfolding, exemplified by monogenic diabetes mellitus due to mutations in proinsulin leading to endoplasmic reticulum...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 47; pp. 29618 - 29628 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
24.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Proteins have evolved to be foldable, and yet determinants of foldability may be inapparent once the native state is reached. Insight has emerged from studies of diseases of protein misfolding, exemplified by monogenic diabetes mellitus due to mutations in proinsulin leading to endoplasmic reticulum stress and β-cell death. Cellular foldability of human proinsulin requires an invariant Phe within a conserved crevice at the receptor-binding surface (position B24). Any substitution, even related aromatic residue TyrB24, impairs insulin biosynthesis and secretion. As a seeming paradox, a monomeric TyrB24 insulin analog exhibits a native-like structure in solution with only a modest decrement in stability. Packing of TyrB24 is similar to that of PheB24, adjoining core cystine B19–A20 to seal the core; the analog also exhibits native self-assembly. Although affinity for the insulin receptor is decreased ∼20-fold, biological activities in cells and rats were within the range of natural variation. Together, our findings suggest that the invariance of PheB24 among vertebrate insulins and insulin-like growth factors reflects an essential role in enabling efficient protein folding, trafficking, and secretion, a function that is inapparent in native structures. In particular, we envision that the para-hydroxyl group of TyrB24 hinders pairing of cystine B19–A20 in an obligatory on-pathway folding intermediate. The absence of genetic variation at B24 and other conserved sites near this disulfide bridge—excluded due to β-cell dysfunction—suggests that insulin has evolved to the edge of foldability. Nonrobustness of a protein’s fitness landscape underlies both a rare monogenic syndrome and “diabesity” as a pandemic disease of civilization. |
---|---|
Bibliography: | Author contributions: N.K.R., M.L., F.I.-B., N.B.P., P.A., and M.A.W. designed research; N.K.R., M.L., Y.Y., B.D., N.P.W., Y.-S.C., L.R., H.G., L.H., J.S., and F.I.-B. performed research; N.K.R., M.L., Y.Y., B.D., N.P.W., Y.-S.C., and M.A.W. analyzed data; and N.K.R., N.B.P., P.A., and M.A.W. wrote the paper. Edited by Barbara B. Kahn, Beth Israel Deaconess Medical Center, Boston, MA, and approved September 21, 2020 (received for review May 29, 2020) 1N.K.R., M.L., and Y.Y. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2010908117 |